BioMarin Pharmaceutical Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2007 | — | — | $228.3M |
| FY2008 | — | — | $222.9M |
| FY2009 | $595.0M | $917.2M | $167.2M |
| FY2010 | $545.4M | $1.26B | $88.1M |
| FY2011 | $532.7M | $1.31B | $46.3M |
| FY2012 | $552.6M | $1.57B | $180.5M |
| FY2013 | $903.0M | $2.24B | $568.8M |
| FY2014 | $947.5M | $2.48B | $875.5M |
| FY2015 | $1.33B | $3.73B | $397.0M |
| FY2016 | $1.26B | $4.02B | $408.3M |
| FY2017 | $1.82B | $4.63B | $598.0M |
| FY2018 | $1.46B | $4.43B | $494.0M |
| FY2019 | $1.57B | $4.69B | $437.4M |
| FY2020 | $1.74B | $5.85B | $649.2M |
| FY2021 | $1.74B | $6.00B | $587.3M |
| FY2022 | $1.77B | $6.38B | $724.5M |
| FY2023 | $1.89B | $6.84B | $755.1M |
| FY2024 | $1.33B | $6.99B | $942.8M |
| FY2025 | $1.51B | $7.59B | $1.31B |